[HTML][HTML] Bi-and trispecific immune cell engagers for immunotherapy of hematological malignancies
A Tapia-Galisteo, L Álvarez-Vallina, L Sanz - Journal of Hematology & …, 2023 - Springer
Immune cell engagers are engineered antibodies with at least one arm binding a tumor-
associated antigen and at least another one directed against an activating receptor in …
associated antigen and at least another one directed against an activating receptor in …
Bi-and trispecific immune cell engagers for immunotherapy of hematological malignancies.
A Tapia-Galisteo, L Álvarez-Vallina… - Journal of Hematology …, 2023 - search.ebscohost.com
Immune cell engagers are engineered antibodies with at least one arm binding a tumor-
associated antigen and at least another one directed against an activating receptor in …
associated antigen and at least another one directed against an activating receptor in …
[HTML][HTML] Bi-and trispecific immune cell engagers for immunotherapy of hematological malignancies
A Tapia-Galisteo, L Álvarez-Vallina… - Journal of Hematology & …, 2023 - ncbi.nlm.nih.gov
Immune cell engagers are engineered antibodies with at least one arm binding a tumor-
associated antigen and at least another one directed against an activating receptor in …
associated antigen and at least another one directed against an activating receptor in …
Bi-and trispecific immune cell engagers for immunotherapy of hematological malignancies.
A Tapia-Galisteo, L Álvarez-Vallina… - Journal of Hematology & …, 2023 - europepmc.org
Immune cell engagers are engineered antibodies with at least one arm binding a tumor-
associated antigen and at least another one directed against an activating receptor in …
associated antigen and at least another one directed against an activating receptor in …
Bi-and trispecific immune cell engagers for immunotherapy of hematological malignancies
A Tapia-Galisteo… - … of hematology & …, 2023 - pubmed.ncbi.nlm.nih.gov
Immune cell engagers are engineered antibodies with at least one arm binding a tumor-
associated antigen and at least another one directed against an activating receptor in …
associated antigen and at least another one directed against an activating receptor in …
Bi-and trispecific immune cell engagers for immunotherapy of hematological malignancies
A Tapia-Galisteo, L Álvarez-Vallina… - Journal of Hematology …, 2023 - search.proquest.com
Immune cell engagers are engineered antibodies with at least one arm binding a tumor-
associated antigen and at least another one directed against an activating receptor in …
associated antigen and at least another one directed against an activating receptor in …
[HTML][HTML] Bi-and trispecific immune cell engagers for immunotherapy of hematological malignancies
A Tapia-Galisteo… - … of Hematology & …, 2023 - jhoonline.biomedcentral.com
Immune cell engagers are engineered antibodies with at least one arm binding a tumor-
associated antigen and at least another one directed against an activating receptor in …
associated antigen and at least another one directed against an activating receptor in …
[PDF][PDF] Bi‑and trispecific immune cell engagers for immunotherapy of hematological malignancies
A Tapia‑Galisteo… - … of Hematology & …, 2023 - jhoonline.biomedcentral.com
Immune cell engagers are engineered antibodies with at least one arm binding a tumor‑
associated antigen and at least another one directed against an activating receptor in …
associated antigen and at least another one directed against an activating receptor in …
[引用][C] Bi‑and trispecific immune cell engagers for immunotherapy of hematological malignancies
A Tapia‑Galisteo, L Álvarez‑Vallina… - Journal of Hematology & …, 2023 - europepmc.org
Immune cell engagers are engineered antibodies with at least one arm binding a tumor‑
associated antigen and at least another one directed against an activating receptor in …
associated antigen and at least another one directed against an activating receptor in …